C3 and kidney disorder: These data indicated that in the absence of FH (and FI) regulation, the availability of additional intact C3, as a result of less activation driven at surfaces, and consequently more intact C3 being available in the fluid phase, was actually detrimental and that this scenario must be avoided in treatment of renal diseases.94, 95